
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $2.9B | $3.5B | $3.8B | $3.9B | $3.8B | |
Revenue Growth (YoY) | -3.26% | 22.23% | 6.08% | 2.64% | -0.9% | |
Cost of Revenues | $1.8B | $2.2B | $2.4B | $2.4B | $2.4B | |
Gross Profit | $1.1B | $1.3B | $1.3B | $1.5B | $1.5B | |
Gross Profit Margin | 38.28% | 37.04% | 35.42% | 38.54% | 38.14% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $660.3M | $701.4M | $670.9M | $727.4M | $739.3M | |
Other Inc / (Exp) | $3.3M | $20.4M | -$425.6M | -$11.9M | -$9.1M | |
Operating Expenses | $660.3M | $701.4M | $670.9M | $727.4M | $739.3M | |
Operating Income | $447.9M | $609.5M | $658.7M | $757.4M | $716.8M | |
Net Interest Expenses | $7.3M | $4.3M | $9.4M | $12M | $6.7M | |
EBT. Incl. Unusual Items | $443.9M | $625.6M | $223.7M | $733.5M | $701M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $99M | $138.5M | -$12M | $176.9M | $167.4M | |
Net Income to Company | $344.9M | $487.1M | $235.7M | $556.6M | $533.6M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $344.9M | $487.1M | $235.7M | $556.6M | $533.6M | |
Basic EPS (Cont. Ops) | $2.13 | $3.05 | $1.52 | $3.71 | $3.65 | |
Diluted EPS (Cont. Ops) | $2.12 | $3.02 | $1.51 | $3.69 | $3.63 | |
Weighted Average Basic Share | $161.5M | $159.9M | $154.8M | $150M | $146M | |
Weighted Average Diluted Share | $162.6M | $161.3M | $155.8M | $151M | $147.1M | |
EBITDA | $531.2M | $707.8M | $310M | $823.8M | $786.5M | |
EBIT | $451.2M | $629.9M | $233.1M | $745.5M | $707.7M | |
Revenue (Reported) | $2.9B | $3.5B | $3.8B | $3.9B | $3.8B | |
Operating Income (Reported) | $447.9M | $609.5M | $658.7M | $757.4M | $716.8M | |
Operating Income (Adjusted) | $451.2M | $629.9M | $233.1M | $745.5M | $707.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $769M | $977.7M | $966.4M | $978.8M | $963.9M | |
Revenue Growth (YoY) | 20.74% | 27.14% | -1.16% | 1.28% | -1.52% | |
Cost of Revenues | $480.4M | $636.1M | $592.3M | $594.1M | $588.5M | |
Gross Profit | $288.6M | $341.6M | $374.1M | $384.7M | $375.4M | |
Gross Profit Margin | 37.53% | 34.94% | 38.71% | 39.3% | 38.95% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $166.5M | $179.8M | $187.2M | $192.2M | $192.6M | |
Other Inc / (Exp) | $5M | -$3.7M | -$11.6M | $1.2M | $1.2M | |
Operating Expenses | $166.5M | $179.8M | $187.2M | $192.2M | $192.6M | |
Operating Income | $122.1M | $161.8M | $186.9M | $192.5M | $182.8M | |
Net Interest Expenses | $1M | $1.5M | $4M | $1M | $2.9M | |
EBT. Incl. Unusual Items | $126.1M | $156.6M | $171.3M | $192.7M | $181.1M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $28.4M | $36.8M | $44.4M | $45.1M | $44.5M | |
Net Income to Company | $97.7M | $119.8M | $126.9M | $147.6M | $136.6M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $97.7M | $119.8M | $126.9M | $147.6M | $136.6M | |
Basic EPS (Cont. Ops) | $0.60 | $0.76 | $0.84 | $1.00 | $0.95 | |
Diluted EPS (Cont. Ops) | $0.60 | $0.76 | $0.84 | $1.00 | $0.95 | |
Weighted Average Basic Share | $161.5M | $157M | $150.9M | $147.2M | $143.6M | |
Weighted Average Diluted Share | $162.8M | $158.3M | $151.9M | $148.3M | $144.4M | |
EBITDA | $146.6M | $178.4M | $194.5M | $213.3M | $204.7M | |
EBIT | $127.1M | $158.1M | $175.3M | $193.7M | $184M | |
Revenue (Reported) | $769M | $977.7M | $966.4M | $978.8M | $963.9M | |
Operating Income (Reported) | $122.1M | $161.8M | $186.9M | $192.5M | $182.8M | |
Operating Income (Adjusted) | $127.1M | $158.1M | $175.3M | $193.7M | $184M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $3B | $3.7B | $3.7B | $3.9B | $3.8B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $1.9B | $2.4B | $2.4B | $2.4B | $2.4B | |
Gross Profit | $1.2B | $1.4B | $1.4B | $1.5B | $1.4B | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $653M | $714.7M | $678.3M | $732.4M | $739.7M | |
Other Inc / (Exp) | $4.1M | $11.7M | -$433.5M | $900K | -$9.1M | |
Operating Expenses | $653M | $714.7M | $678.3M | $732.4M | $739.7M | |
Operating Income | $504.3M | $649.2M | $683.8M | $763M | $707.1M | |
Net Interest Expenses | $6.1M | $4.8M | $11.9M | $9M | $8.6M | |
EBT. Incl. Unusual Items | $502.3M | $656.1M | $238.4M | $754.9M | $689.4M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $111.4M | $146.9M | -$4.4M | $177.6M | $166.8M | |
Net Income to Company | $390.9M | $509.2M | $242.8M | $577.3M | $522.6M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $390.9M | $509.2M | $242.8M | $577.3M | $522.6M | |
Basic EPS (Cont. Ops) | $2.41 | $3.22 | $1.57 | $3.86 | $3.59 | |
Diluted EPS (Cont. Ops) | $2.41 | $3.18 | $1.57 | $3.86 | $3.58 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $587.8M | $739.6M | $326.1M | $842.6M | $777.9M | |
EBIT | $508.4M | $660.9M | $250.3M | $763.9M | $698M | |
Revenue (Reported) | $3B | $3.7B | $3.7B | $3.9B | $3.8B | |
Operating Income (Reported) | $504.3M | $649.2M | $683.8M | $763M | $707.1M | |
Operating Income (Adjusted) | $508.4M | $660.9M | $250.3M | $763.9M | $698M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $769M | $977.7M | $966.4M | $978.8M | $963.9M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $480.4M | $636.1M | $592.3M | $594.1M | $588.5M | |
Gross Profit | $288.6M | $341.6M | $374.1M | $384.7M | $375.4M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $166.5M | $179.8M | $187.2M | $192.2M | $192.6M | |
Other Inc / (Exp) | $5M | -$3.7M | -$11.6M | $1.2M | $1.2M | |
Operating Expenses | $166.5M | $179.8M | $187.2M | $192.2M | $192.6M | |
Operating Income | $122.1M | $161.8M | $186.9M | $192.5M | $182.8M | |
Net Interest Expenses | $1M | $1.5M | $4M | $1M | $2.9M | |
EBT. Incl. Unusual Items | $126.1M | $156.6M | $171.3M | $192.7M | $181.1M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $28.4M | $36.8M | $44.4M | $45.1M | $44.5M | |
Net Income to Company | $97.7M | $119.8M | $126.9M | $147.6M | $136.6M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $97.7M | $119.8M | $126.9M | $147.6M | $136.6M | |
Basic EPS (Cont. Ops) | $0.60 | $0.76 | $0.84 | $1.00 | $0.95 | |
Diluted EPS (Cont. Ops) | $0.60 | $0.76 | $0.84 | $1.00 | $0.95 | |
Weighted Average Basic Share | $161.5M | $157M | $150.9M | $147.2M | $143.6M | |
Weighted Average Diluted Share | $162.8M | $158.3M | $151.9M | $148.3M | $144.4M | |
EBITDA | $146.6M | $178.4M | $194.5M | $213.3M | $204.7M | |
EBIT | $127.1M | $158.1M | $175.3M | $193.7M | $184M | |
Revenue (Reported) | $769M | $977.7M | $966.4M | $978.8M | $963.9M | |
Operating Income (Reported) | $122.1M | $161.8M | $186.9M | $192.5M | $182.8M | |
Operating Income (Adjusted) | $127.1M | $158.1M | $175.3M | $193.7M | $184M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $573.1M | $443.3M | $391.2M | $339.9M | $239.6M | |
Short Term Investments | $116.5M | $188.1M | $90.6M | $23.5M | $36.5M | |
Accounts Receivable, Net | $585M | $634.4M | $581.2M | $596M | $541.4M | |
Inventory | $300.1M | $447.7M | $516.4M | $497.4M | $532.1M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $43.3M | $39.1M | $54.3M | $43.5M | $43.3M | |
Total Current Assets | $1.6B | $1.8B | $1.6B | $1.5B | $1.4B | |
Property Plant And Equipment | $582.9M | $639.2M | $620.5M | $634.8M | $661.5M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $546.8M | $627.8M | $619.7M | $633.4M | $761.7M | |
Other Intangibles | $323.9M | $364.8M | $347.9M | $336.7M | $321.1M | |
Other Long-Term Assets | $89.1M | $90M | $110.5M | $108.7M | $102.8M | |
Total Assets | $3.2B | $3.5B | $3.3B | $3.2B | $3.2B | |
Accounts Payable | $595.2M | $745.9M | $625.8M | $600.4M | $588.7M | |
Accrued Expenses | $236.5M | $295.2M | $234.8M | $269.6M | $231.5M | |
Current Portion Of Long-Term Debt | -- | -- | $10M | $10M | $10M | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $886.3M | $1.1B | $934.2M | $945.3M | $897.2M | |
Long-Term Debt | $106.4M | $189.9M | $334.5M | $117.3M | $183.2M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $1.3B | $1.6B | $1.6B | $1.4B | $1.4B | |
Common Stock | $295.4M | $295.2M | $294.9M | $294.8M | $294.8M | |
Other Common Equity Adj | -$321.2M | -$331.4M | -$82.4M | -$84.2M | -$111.9M | |
Common Equity | $1.8B | $1.8B | $1.7B | $1.8B | $1.9B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $1.8B | $1.8B | $1.7B | $1.8B | $1.9B | |
Total Liabilities and Equity | $3.2B | $3.5B | $3.3B | $3.2B | $3.2B | |
Cash and Short Terms | $689.6M | $631.4M | $481.8M | $363.4M | $276.1M | |
Total Debt | $113.2M | $196.7M | $344.5M | $127.3M | $193.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $578.5M | $405.8M | $406.2M | $251.6M | $173M | |
Short Term Investments | $87M | $173.6M | $89.8M | $51.5M | $27.2M | |
Accounts Receivable, Net | $534.5M | $608.3M | $586.8M | $584.6M | $641.5M | |
Inventory | $312.8M | $488.7M | $503.7M | $522.3M | $532.6M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $45.4M | $45M | $57.3M | $51.5M | $47.8M | |
Total Current Assets | $1.6B | $1.7B | $1.6B | $1.5B | $1.4B | |
Property Plant And Equipment | $583.3M | $636.7M | $617.8M | $634.7M | $669M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $547.3M | $628.8M | $619.9M | $651.5M | $707.1M | |
Other Intangibles | $320.9M | $360.4M | $344.8M | $333.5M | $373.9M | |
Other Long-Term Assets | $97.1M | $87.6M | $110M | $101M | $95.6M | |
Total Assets | $3.1B | $3.4B | $3.3B | $3.2B | $3.3B | |
Accounts Payable | $547.4M | $658.7M | $550.4M | $557.7M | $541M | |
Accrued Expenses | $236.3M | $268.4M | $273.5M | $251.4M | $261.3M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $836.1M | $1B | $895.7M | $883.4M | $882.1M | |
Long-Term Debt | $99.6M | $288.6M | $330.8M | $109.7M | $259.8M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $1.3B | $1.6B | $1.5B | $1.3B | $1.4B | |
Common Stock | $295.3M | $295.2M | $294.9M | $294.8M | $294.7M | |
Other Common Equity Adj | -$320.8M | -$327.6M | -$80M | -$87.9M | -$110.3M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $1.8B | $1.8B | $1.8B | $1.9B | $1.9B | |
Total Liabilities and Equity | $3.1B | $3.4B | $3.3B | $3.2B | $3.3B | |
Cash and Short Terms | $665.5M | $579.4M | $496M | $303.1M | $200.2M | |
Total Debt | $106.4M | $295.4M | $340.8M | $119.7M | $269.8M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $344.9M | $487.1M | $235.7M | $556.6M | $533.6M | |
Depreciation & Amoritzation | $80M | $77.9M | $76.9M | $78.3M | $78.8M | |
Stock-Based Compensation | $12.7M | $11.9M | $11.1M | $11.5M | $14.9M | |
Change in Accounts Receivable | $4.5M | -$25.5M | $42.5M | -$16.4M | $49M | |
Change in Inventories | $2.9M | -$109.5M | -$82.8M | $18.1M | -$40.5M | |
Cash From Operations | $562.1M | $641.1M | $391.4M | $670.3M | $581.8M | |
Capital Expenditures | $56.8M | $75.1M | $70.3M | $72.6M | $108M | |
Cash Acquisitions | -- | -$207.6M | -$8M | -$16.8M | -$145.9M | |
Cash From Investing | $11.8M | -$349.9M | $8.1M | -$24.1M | -$267.1M | |
Dividends Paid (Ex Special Dividend) | -$158.7M | -$170.1M | -$177.2M | -$183.5M | -$190.4M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -$56.7M | -$366.5M | -$403.5M | -$306.5M | -$305.8M | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -$374.8M | -$421M | -$430.8M | -$684.7M | -$408.4M | |
Beginning Cash (CF) | $374M | $573.1M | $443.3M | $391.2M | $339.9M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $199.1M | -$129.8M | -$31.3M | -$38.5M | -$93.7M | |
Ending Cash (CF) | $573.1M | $443.3M | $391.2M | $339.9M | $239.6M | |
Levered Free Cash Flow | $505.3M | $566M | $321.1M | $597.7M | $473.8M |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $118.2M | $126.2M | $157M | $156.2M | -- | |
Depreciation & Amoritzation | $19.5M | $18M | $18.9M | $19.6M | -- | |
Stock-Based Compensation | $1.5M | $1.4M | $1.6M | $2.1M | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $91.6M | $37.9M | $140.3M | $57.4M | -- | |
Capital Expenditures | $13.6M | $17.8M | $13.5M | $22.9M | -- | |
Cash Acquisitions | -- | -$8M | -- | -$200K | -- | |
Cash From Investing | -$62.5M | $38.8M | $43.6M | $11.1M | -- | |
Dividends Paid (Ex Special Dividend) | -$41.7M | -$43.7M | -$45.2M | -$46.9M | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -$131.1M | -$82.5M | -$16.5M | -$78.7M | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -$162.8M | -$123.1M | -$193.7M | -$103.1M | -- | |
Beginning Cash (CF) | $578.5M | $405.8M | $406.2M | $251.6M | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -$17.5M | -$900K | -- | |
Additions / Reductions | -$133.7M | -$46.4M | -$9.8M | -$34.6M | -- | |
Ending Cash (CF) | $444.8M | $359.4M | $378.9M | $216.1M | -- | |
Levered Free Cash Flow | $78M | $20.1M | $126.8M | $34.5M | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $390.9M | $509.2M | $242.8M | $577.3M | $522.6M | |
Depreciation & Amoritzation | $79.4M | $78.7M | $75.8M | $78.7M | $79.9M | |
Stock-Based Compensation | $11.1M | $12.1M | $10.5M | $12.8M | $12.7M | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $612.4M | $553.2M | $494.8M | $657M | $513.9M | |
Capital Expenditures | $61.1M | $70.9M | $68.1M | $83.9M | $107.3M | |
Cash Acquisitions | -- | -$207.6M | -$8M | -$37.9M | -$124.8M | |
Cash From Investing | -$2.1M | -$360.3M | -$3.8M | -$85.5M | -$206.7M | |
Dividends Paid (Ex Special Dividend) | -$161.9M | -$172.1M | -$178.4M | -$185.4M | -$192.3M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -$67M | -$407.4M | -$348.7M | -$327.9M | -$351.9M | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -$447.9M | -$365.6M | -$472.2M | -$707.8M | -$382.9M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $162.4M | -$172.7M | $18.8M | -$136.3M | -$75.7M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $551.3M | $482.3M | $426.7M | $573.1M | $406.6M |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $215.9M | $246M | $283.9M | $303.8M | $136.6M | |
Depreciation & Amoritzation | $39M | $38.3M | $38.1M | $39.2M | $20.7M | |
Stock-Based Compensation | $8.9M | $9M | $8.6M | $10.4M | $6.1M | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $196M | $54.4M | $260.2M | $164M | $38.7M | |
Capital Expenditures | $30.7M | $30.7M | $24.2M | $44.9M | $21.3M | |
Cash Acquisitions | -- | -$8M | -- | -$21.3M | -- | |
Cash From Investing | -$50M | $40.9M | $33.8M | -$60.1M | -$10.8M | |
Dividends Paid (Ex Special Dividend) | -$83.9M | -$87.9M | -$90.6M | -$94.2M | -$49.2M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -$198.1M | -$190.4M | -$69.6M | -$153.2M | -$120.6M | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -$274.3M | -$179.2M | -$291.2M | -$223.7M | -$95.1M | |
Beginning Cash (CF) | $1.2B | $849.1M | $797.4M | $591.5M | $239.6M | |
Foreign Exchange Rate Adjustment | -- | -- | -$15.1M | -$4M | $600K | |
Additions / Reductions | -$128.3M | -$83.9M | $2.8M | -$119.8M | -$67.2M | |
Ending Cash (CF) | $1B | $765.2M | $785.1M | $467.7M | $173M | |
Levered Free Cash Flow | $165.3M | $23.7M | $236M | $119.1M | $17.4M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.